David Barras

8.4k total citations
31 papers, 1.1k citations indexed

About

David Barras is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, David Barras has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in David Barras's work include Cancer Immunotherapy and Biomarkers (7 papers), Genetic factors in colorectal cancer (6 papers) and CAR-T cell therapy research (5 papers). David Barras is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Genetic factors in colorectal cancer (6 papers) and CAR-T cell therapy research (5 papers). David Barras collaborates with scholars based in Switzerland, United States and Belgium. David Barras's co-authors include Christian Widmann, Mauro Delorenzi, Sabine Tejpar, Curzio Rüegg, Girieca Lorusso, Daniel D. Pinschewer, Francesca Alfei, Vijaykumar Chennupati, Dietmar Zehn and Daniel T. Utzschneider and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

David Barras

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Barras Switzerland 19 588 487 247 186 186 31 1.1k
Stacey M. Bagby United States 21 516 0.9× 568 1.2× 194 0.8× 94 0.5× 242 1.3× 62 1.1k
Lunxi Liang China 10 457 0.8× 503 1.0× 299 1.2× 88 0.5× 267 1.4× 16 1.0k
Miriam Redrado Spain 20 518 0.9× 544 1.1× 233 0.9× 80 0.4× 270 1.5× 39 1.1k
Kavitha Balaji United States 9 381 0.6× 320 0.7× 229 0.9× 92 0.5× 105 0.6× 15 829
Sander R. van Hooff Netherlands 16 362 0.6× 528 1.1× 164 0.7× 140 0.8× 223 1.2× 29 1.0k
Julianne D. Twomey United States 10 504 0.9× 302 0.6× 256 1.0× 145 0.8× 93 0.5× 18 988
Laura Stanbery United States 17 557 0.9× 441 0.9× 273 1.1× 85 0.5× 242 1.3× 54 1.1k
Yang Peng United States 12 789 1.3× 906 1.9× 287 1.2× 229 1.2× 216 1.2× 27 1.4k
Desheng Weng China 20 466 0.8× 662 1.4× 353 1.4× 79 0.4× 189 1.0× 59 1.2k
Isabelle Matte Canada 20 424 0.7× 514 1.1× 403 1.6× 80 0.4× 200 1.1× 22 1.2k

Countries citing papers authored by David Barras

Since Specialization
Citations

This map shows the geographic impact of David Barras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Barras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Barras more than expected).

Fields of papers citing papers by David Barras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Barras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Barras. The network helps show where David Barras may publish in the future.

Co-authorship network of co-authors of David Barras

This figure shows the co-authorship network connecting the top 25 collaborators of David Barras. A scholar is included among the top collaborators of David Barras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Barras. David Barras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perez, Marta A. S., Johanna Chiffelle, Sara Bobisse, et al.. (2024). Predicting Antigen‐Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist. Advanced Science. 11(40). e2405949–e2405949. 5 indexed citations
2.
Lorusso, Girieca, François Kuonen, Nicola Vannini, et al.. (2022). Connexins orchestrate progression of breast cancer metastasis to the brain by promoting FAK activation. Science Translational Medicine. 14(661). eaax8933–eaax8933. 28 indexed citations
3.
Ghisoni, Eleonora, Fabrizio Benedetti, Paula Cunnea, et al.. (2022). 27MO Integrated digital pathology and single-cell analysis identify the spatial and temporal evolution of immune cells networks in epithelial ovarian cancer. Annals of Oncology. 33. S395–S395. 1 indexed citations
4.
Baumgaertner, Petra, Martial Sankar, Fernanda Herrera, et al.. (2021). Unsupervised Analysis of Flow Cytometry Data in a Clinical Setting Captures Cell Diversity and Allows Population Discovery. Frontiers in Immunology. 12. 633910–633910. 11 indexed citations
5.
McCuaig, Sarah, David Barras, Elizabeth H. Mann, et al.. (2020). The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer. Clinical Cancer Research. 26(16). 4313–4325. 23 indexed citations
6.
Ragusa, Simone, Alejandra González‐Loyola, Sina Nassiri, et al.. (2020). Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice. Journal of Clinical Investigation. 130(3). 1199–1216. 44 indexed citations
7.
Bonnans, Caroline, Delphine Grün, Chih‐Yang Wang, et al.. (2019). RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer. JCI Insight. 4(15). 18 indexed citations
8.
Nisa, Lluís, David Barras, Michaela Medová, et al.. (2018). Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease. Molecular Cancer Research. 16(12). 1912–1926. 23 indexed citations
9.
Lan, Qiang, Sanam Peyvandi, Yu-Ting Huang, et al.. (2018). Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer. Oncogene. 38(15). 2814–2829. 84 indexed citations
10.
Castro, Wilson, Sonia T. Chelbi, Suzanne P. M. Welten, et al.. (2018). The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity. Nature Immunology. 19(8). 809–820. 42 indexed citations
11.
Neubert, Natalie J., Laure Tillé, David Barras, et al.. (2017). Broad and Conserved Immune Regulation by Genetically Heterogeneous Melanoma Cells. Cancer Research. 77(7). 1623–1636. 8 indexed citations
12.
Jacquier, Nicolas, Sébastien Aeby, Didier Le Roy, et al.. (2017). The Anticancer Peptide TAT-RasGAP317−326 Exerts Broad Antimicrobial Activity. Frontiers in Microbiology. 8. 994–994. 21 indexed citations
13.
Barras, David, Edoardo Missiaglia, Pratyaksha Wirapati, et al.. (2016). BRAF   V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression. Clinical Cancer Research. 23(1). 104–115. 161 indexed citations
14.
Flahaut, Marjorie, Katya Nardou, Katia Balmas Bourloud, et al.. (2016). Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma. BMC Cancer. 16(1). 781–781. 39 indexed citations
15.
Smedt, Linde De, Sofie Palmans, Olivier Govaere, et al.. (2016). Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching. British Journal of Cancer. 116(1). 58–65. 129 indexed citations
16.
Moor, Andreas E., Pascale Anderle, Claudio Cantù, et al.. (2015). BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer. EBioMedicine. 2(12). 1932–1943. 44 indexed citations
17.
Barras, David, Vincent Zoete, Karine Lapouge, et al.. (2014). A WXW Motif Is Required for the Anticancer Activity of the TAT-RasGAP317–326 Peptide. Journal of Biological Chemistry. 289(34). 23701–23711. 20 indexed citations
18.
Barras, David & Christian Widmann. (2013). GAP-independent functions of DLC1 in metastasis. Cancer and Metastasis Reviews. 33(1). 87–100. 31 indexed citations
19.
Barras, David, Girieca Lorusso, Curzio Rüegg, & Christian Widmann. (2013). Inhibition of cell migration and invasion mediated by the TAT-RasGAP317–326 peptide requires the DLC1 tumor suppressor. Oncogene. 33(44). 5163–5172. 20 indexed citations
20.
Barras, David & Christian Widmann. (2011). Promises of Apoptosis-Inducing Peptides in Cancer Therapeutics. Current Pharmaceutical Biotechnology. 12(8). 1153–1165. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stacey M. Bagby Breakdown of academic impact, for papers by Lunxi Liang Breakdown of academic impact, for papers by Miriam Redrado Breakdown of academic impact, for papers by Kavitha Balaji Breakdown of academic impact, for papers by Sander R. van Hooff Breakdown of academic impact, for papers by Julianne D. Twomey Breakdown of academic impact, for papers by Laura Stanbery Breakdown of academic impact, for papers by Yang Peng Breakdown of academic impact, for papers by Desheng Weng Breakdown of academic impact, for papers by Isabelle Matte
Rankless by CCL
2026